Test Menu

BCL6/MYC t(3;8) Alternative Name BCL6/MYC Translocation Methodology FISH Test Description Probes: BCL6/MYC t(3;8) Disease(s): B-cell lymphoma, double-hit lymphoma,…

CMV ISH Alternative Name Cytomegalovirus by ISH Methodology In Situ Hybridization (ISH) Test Description In situ hybridization for detection of cytomegalovirus (CMV)…

FOLR1 FDA (ELAHERE™) for Ovarian Carcinoma Alternative Name FOLR1 IHC CDx, Folate Receptor alpha (FRα), FOLR1 (FOLR1-2.1) RxDx Assay Methodology Immunohistochemistry (IHC) Test…

Microsatellite Instability (MSI) by PCR Alternative Name Microsatellite Instability Analysis Methodology Molecular Test Description PCR and fragment analysis of paired…

Neo Comprehensive - Solid Tumor Methodology Molecular Test Description Neo Comprehensive™ - Solid Tumor is a broad, next-generation sequencing panel for pan-solid tumor indications. The assay detects…

Neo Comprehensive™ - Myeloid Disorders Alternative Name Comprehensive Myeloid Disorders, Myeloid CGP, Comprehensive Myeloid Methodology Molecular Test Description The…

NeoTYPE® DNA & RNA - Brain Alternative Name Brain Tumor Profile Methodology Molecular Test Description NeoTYPE® DNA & RNA - Brain uses targeted next-generation…

NeoTYPE® DNA & RNA - Lung Methodology Molecular Test Description NeoTYPE® DNA & RNA - Lung is a targeted next-generation sequencing profile that detects single nucleotide variants (SNV),…

PD-L1 28-8 (OPDIVO®) for Gastric/GEJ/EAC Alternative Name PD-L1 28-8 (OPDIVO®) for Gastric/GEJ/Esophageal Adenocarcinoma Methodology Immunohistochemistry (IHC) Test Description…

RaDaR® Methodology Molecular Test Description RaDaR is a tumor-informed liquid biopsy test for the detection of minimal or molecular residual disease (MRD). RaDaR can be utilized for patients with…